Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Olympus Corp, Sony Corp Say Medical Business Merger Delayed-Reuters


Thursday, 20 Dec 2012 09:54pm EST 

Reuters reported that Olympus Corp and Sony Corp said that a planned merger of the two firms' medical business will take longer than expected due to delays in obtaining regulatory approval abroad. The companies are working to establish the venture by April 2013, but did not specify the countries where the firms were facing delays in regulatory approval. Sony said in September that it would pay JPY50 billion ($590 million) to become the biggest shareholder in Olympus and planned to establish a company by the end of the year with the cash-strapped camera and endoscope maker to develop medical equipment. 

Company Quote

17.4
0.04 +0.23%
23 Sep 2014